Moximed secured $40 million in Series C equity and debt financing. Proceeds will be used to gain regulatory approvals and establish commercial infrastructure for the MISHA™ Knee System, reported to be the world’s first implantable shock absorber (ISA) for the knee.
Moximed utilized clinically established benefits of weight load reduction on diseased joints to design the MISHA Knee. Implanted during an outpatient procedure, MISHA has been shown to alleviate pain, improve function and potentially delay the need for total knee replacement in some patients.
Anton Clifford, Ph.D., Moximed CEO, said, “Results from our pivotal study show the MISHA Knee System not only alleviates pain and OA-induced activity limitations, but also offers complete preservation of the knee, an outpatient procedure, and early weight bearing. These are all strong preferences expressed by our patient population.”
Moximed secured $40 million in Series C equity and debt financing. Proceeds will be used to gain regulatory approvals and establish commercial infrastructure for the MISHA™ Knee System, reported to be the world’s first implantable shock absorber (ISA) for the knee.
Moximed utilized clinically established benefits of weight load reduction on...
Moximed secured $40 million in Series C equity and debt financing. Proceeds will be used to gain regulatory approvals and establish commercial infrastructure for the MISHA™ Knee System, reported to be the world’s first implantable shock absorber (ISA) for the knee.
Moximed utilized clinically established benefits of weight load reduction on diseased joints to design the MISHA Knee. Implanted during an outpatient procedure, MISHA has been shown to alleviate pain, improve function and potentially delay the need for total knee replacement in some patients.
Anton Clifford, Ph.D., Moximed CEO, said, “Results from our pivotal study show the MISHA Knee System not only alleviates pain and OA-induced activity limitations, but also offers complete preservation of the knee, an outpatient procedure, and early weight bearing. These are all strong preferences expressed by our patient population.”
Copy to clipboard 
